A bulk deal in the stock market refers to a transaction where a single entity, such as an institutional investor or a prominent trader, buys or sells a large quantity of a company’s shares.
Specifically, it involves trading more than 0.5 percent of a company’s total equity shares listed in a particular exchange, either in single or multiple transactions during regular trading hours.
According to the latest bulk deal data from the NSE, here are two micro-cap stocks priced under Rs. 300 that have experienced share price fluctuations following stake acquisitions by foreign institutional investors (FIIs):
Nephro Care India Limited
With a market cap of Rs. 480.6 crores, the stock surged by 5 percent on NSE to Rs. 311.65 on Thursday, as against its previous closing price of Rs. 296.85.
The foreign investor Aegis Investment Fund PCC bought around 1.31 lakh equity shares in Nephro Care India, at an average price of Rs. 287.85 per share, resulting in a total transaction value of nearly Rs. 3.77 crore.
The company experienced significant growth in its revenue from operations, showing a year-on-year rise of nearly 397 percent from Rs. 3.42 crore in FY21-22 to Rs. 17 crore in FY22-23.
Similarly, its net profit increased during the same period from a loss of Rs. 0.01 crore to a profit of Rs. 1.94 crore.
Incorporated in 2014, Nephro Care India Limited is a healthcare provider specialising in the treatment of kidney-related diseases. It is a comprehensive treatment centre located in Kolkata, offering a wide range of clinical and lifestyle solutions.
Also read
Orient Ceratech Limited
With a market cap of Rs. 613.2 crores, the stock surged by 7.5 percent on BSE to Rs. 52 on Thursday, as against its previous closing price of Rs. 48.38.
The foreign investor Albula Investment Fund Ltd. bought around 32.64 lakh equity shares in Orient Ceratech, at an average price of Rs. 48 per share, resulting in a total transaction value of nearly Rs. 15.6 crore.
The company experienced significant growth in its revenue from operations, showing a year-on-year rise of nearly 11.6 percent from Rs. 284 crores in FY22-23 to Rs. 317 crores in FY23-24.
Similarly, its net profit grew during the same period from Rs. 13 crores to Rs. 17 crores, indicating a growth of 30.8 percent YoY.
The shares of Orient Ceratech delivered positive returns of nearly 47.5 percent, but around 2 percent of negative returns.
Orient Ceratech Limited, previously Orient Abrasive Limited, is principally engaged in the business of production and trading of aluminium refractories and Monolithic products, mining of bauxite ores and generation of power (including windmill facilities).
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
